Intellia Therapeutics
Intellia Therapeutics
intelliatx.com

Locations

Cambridge, MA, USA · Cambridge, MA, USA

industry

Biotechnology · DeepTech · Health

Size

201-1000 employees

Stage

Other

founded in

2014

Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. We are focused on the development of proprietary therapeutics using a recently developed biological tool known as the CRISPR/Cas9 system. The promise of the CRISPR/Cas9 system is the driving force behind the creation of Intellia. Our founders have a shared belief that the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course. This technology offers the potential for us to develop curative therapeutic options for patients with chronic diseases by addressing the underlying cause of the disease. It can bring new hope and cures to people who now have nowhere to turn for help.

Something looks off?
Open jobs at Intellia Therapeutics

On-site & Remote